Guidance
Evidence-based recommendations on selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinoma in adults. This involves injecting tiny radioactive ‘beads’ into blood vessels that supply the liver, where they become trapped and release radiation directly into the cancer cells.
Is this guidance up to date?
Next review: October 2021
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance
This guidance replaces NICE interventional procedures guidance on selective internal radiation therapy for primary intrahepatic cholangiocarcinoma (IPG459).